Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled ciprofloxacin in non-cystic fibrosis bronchiectasis (China RESPIRE)
CTR20140910Phase 3Completed
- Sponsor
- Bayer
- Start
- May 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ciprofloxacin in bronchiectasis, sponsored by Bayer. Started May 2015; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on CTR20140910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140910.